Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppina Caretti

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
Biomedicines|January 28, 2026
Modulation of Bromo- and Extra-Terminal Domain (BET) Proteins Exerts Neuroprotective Effects in Cell Culture Models of Parkinson's DiseaseNoemi Martella, Daniele Pensabene, Mayra Colardo, et al.
Oncotarget|April 21, 2017
Vitamin D and VDR in cancer cachexia and muscle regenerationAndrea Camperi, Fabrizio Pin, Domiziana Costamagna, et al.
Diagnostics (Basel, Switzerland)|November 27, 2021
Sarcopenia Diagnosis: Reliability of the Ultrasound Assessment of the Tibialis Anterior Muscle as an Alternative Evaluation ToolMassimiliano Leigheb, Alessandro de Sire, Matteo Colangelo, et al.
Journal of Cellular Physiology|March 3, 2015
A SMYD3 Small-Molecule Inhibitor Impairing Cancer Cell GrowthAlessia Peserico, Aldo Germani, Paola Sanese, et al.
Nature Communications|November 24, 2017
Epigenetic targeting of bromodomain protein BRD4 counteracts cancer cachexia and prolongs survivalMarco Segatto, Raffaella Fittipaldi, Fabrizio Pin, et al.
European Journal of Medicinal Chemistry|September 18, 2022
Discovery of the 4-aminopiperidine-based compound EM127 for the site-specific covalent inhibition of SMYD3Marco Daniele Parenti, Marina Naldi, Elisabetta Manoni, et al.
Iscience|November 18, 2020
Targeting SMYD3 to Sensitize Homologous Recombination-Proficient Tumors to PARP-Mediated Synthetic LethalityPaola Sanese, Candida Fasano, Giacomo Buscemi, et al.
Nature Metabolism|November 12, 2025
Impaired cAMP-PKA-CREB1 signalling drives mitochondrial dysfunction in skeletal muscle during cancer cachexiaElia Angelino, Lorenza Bodo, Roberta Sartori, et al.
Hepatology (Baltimore, Md.)|September 26, 2020
DCLK1, a Putative Stem Cell Marker in Human CholangiocarcinomaLorenzo Nevi, Sabina Di Matteo, Guido Carpino, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Biomedicines|January 28, 2026
Modulation of Bromo- and Extra-Terminal Domain (BET) Proteins Exerts Neuroprotective Effects in Cell Culture Models of Parkinson's DiseaseNoemi Martella, Daniele Pensabene, Mayra Colardo, et al.
Oncotarget|April 21, 2017
Vitamin D and VDR in cancer cachexia and muscle regenerationAndrea Camperi, Fabrizio Pin, Domiziana Costamagna, et al.
Diagnostics (Basel, Switzerland)|November 27, 2021
Sarcopenia Diagnosis: Reliability of the Ultrasound Assessment of the Tibialis Anterior Muscle as an Alternative Evaluation ToolMassimiliano Leigheb, Alessandro de Sire, Matteo Colangelo, et al.
Journal of Cellular Physiology|March 3, 2015
A SMYD3 Small-Molecule Inhibitor Impairing Cancer Cell GrowthAlessia Peserico, Aldo Germani, Paola Sanese, et al.
Nature Communications|November 24, 2017
Epigenetic targeting of bromodomain protein BRD4 counteracts cancer cachexia and prolongs survivalMarco Segatto, Raffaella Fittipaldi, Fabrizio Pin, et al.
European Journal of Medicinal Chemistry|September 18, 2022
Discovery of the 4-aminopiperidine-based compound EM127 for the site-specific covalent inhibition of SMYD3Marco Daniele Parenti, Marina Naldi, Elisabetta Manoni, et al.
Iscience|November 18, 2020
Targeting SMYD3 to Sensitize Homologous Recombination-Proficient Tumors to PARP-Mediated Synthetic LethalityPaola Sanese, Candida Fasano, Giacomo Buscemi, et al.
Nature Metabolism|November 12, 2025
Impaired cAMP-PKA-CREB1 signalling drives mitochondrial dysfunction in skeletal muscle during cancer cachexiaElia Angelino, Lorenza Bodo, Roberta Sartori, et al.
Hepatology (Baltimore, Md.)|September 26, 2020
DCLK1, a Putative Stem Cell Marker in Human CholangiocarcinomaLorenzo Nevi, Sabina Di Matteo, Guido Carpino, et al.
Pageof 4